AI method predicts retention times of small molecules more reliably

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-01T21:35:22.340Z • Permanent link

Researchers from Friedrich Schiller University Jena have made a groundbreaking discovery that could revolutionize the field of metabolomics, a branch of biochemistry that studies the interactions between small molecules and biological systems. Led by Dr. Elke Dreisbach, the team, in collaboration with partners from the University of California, Berkeley, and the pharmaceutical company, Roche, developed an AI method that can predict the retention times of small molecules in gas chromatography-mass spectrometry (GC-MS) more reliably than existing methods. The study, published in the journal Analytical Chemistry, demonstrates the power of machine learning in accelerating the analysis of complex biological samples.

The breakthrough came after a series of experiments, where the researchers tested various machine learning algorithms on synthetic datasets and compared their performance to traditional methods. They found that their AI approach outperformed the existing methods in predicting retention times, which is critical for identifying and quantifying small molecules in biological samples. The study's findings have far-reaching implications for the pharmaceutical industry, environmental analysis, and metabolomics research, where accurate identification and quantification of small molecules are essential.

The research team's achievement is also significant because it highlights the growing importance of collaboration between academia and industry. The study was conducted in partnership with Roche, a leading pharmaceutical company, and the University of California, Berkeley, which provided access to expertise and resources. The collaboration demonstrates the potential for interdisciplinary research to drive innovation and accelerate the development of new analytical techniques.

The AI method developed by the researchers has the potential to transform the field of metabolomics, where small molecule identification and quantification are critical for understanding biological systems and developing new treatments for diseases. The method's ability to predict retention times more accurately could lead to the development of more efficient and cost-effective analytical workflows, which would enable researchers to analyze larger and more complex datasets. This, in turn, could accelerate the discovery of new biomarkers and therapeutic targets, ultimately leading to the development of more effective treatments for a range of diseases.

The impact of the AI method will be felt across various industries, including pharmaceuticals, environmental analysis, and metabolomics research. Companies like Roche, which are already using GC-MS for small molecule analysis, may adopt the new method to improve the accuracy and efficiency of their workflows. Research communities, including those in academia and government, will also benefit from the method's ability to accelerate the analysis of complex biological samples.

The development of the AI method is part of a broader trend towards the application of machine learning in analytical chemistry. In recent years, there has been a growing recognition of the potential of machine learning to accelerate the analysis of complex biological samples and improve the accuracy and efficiency of analytical workflows. The European Union's Horizon 2020 program, for example, has invested heavily in the development of machine learning algorithms for analytical chemistry applications.